secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001641172-25-015650
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air Q4/FY2025 revenue $3.7M (+220% YoY); guides FY2026 $12-16M; filed PMA for LungFit PH II
--------------------------------------------------------------------------------

- Revenue $3.7M for FY2025, up 220% YoY; net loss $46.6M ($0.69 per share).
- Expects Q1 FY2026 revenue at least $1.7M, full FY2026 revenue $12-16M.
- Submitted PMA supplement to FDA for next-gen LungFit PH II (smaller, transport-ready).
- Appointed Robert Goodman to Board; international distribution covers 2B+ lives.
- Cash $6.9M as of Mar 31, 2025; $2M additional debt financing post-quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000164117225015650/0001641172-25-015650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000164117225015650/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer